Long-Term Cardiac Microvascular Changes in Severe COVID-19 Survivors
Severe COVID-19 survivors may experience prolonged cardiac microvascular dysfunction, impacting blood flow and heart function. New research underscores the importance of understanding these lasting effects for better treatment options.
Recent research from Karolinska Institutet highlights persistent cardiac complications in patients who endured severe COVID-19. The study examined approximately 40 individuals from a post-COVID outpatient clinic using advanced cardiac imaging techniques. Findings revealed reduced blood flow through the heart muscle and impaired pumping function compared to matched controls, suggesting the presence of small vessel disease long after initial infection.
Particularly, patients exhibited signs of microvascular dysfunction, which may contribute to ongoing symptoms like fatigue and exercise intolerance. Midventricular perfusion maps demonstrated globally diminished perfusion under stress conditions, indicating widespread microvascular impairment.
The research emphasizes the importance of understanding the underlying mechanisms of enduring COVID-19 symptoms. As Associate Professor Jannike Nickander explains, small vessel disease could be a key factor and a potential target for therapeutic intervention. Her team is now investigating the molecular pathways involved and exploring the interactions between cardiac and pulmonary pressures in these patients.
This study highlights the need for ongoing monitoring and research into cardiovascular health in COVID-19 survivors, aiming to improve treatment strategies and patient outcomes.
Source: https://medicalxpress.com/news/2025-06-small-vessel-disease-term-severe.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Oral Semaglutide 25 mg Shows Promise for Weight Loss in Overweight and Obese Adults, Trial Finds
A groundbreaking trial reveals that oral semaglutide at 25 mg daily significantly boosts weight loss and improves cardiometabolic health in overweight and obese adults, offering a promising non-injectable treatment option.
Innovative Approach Using Stem Cells and Drug Therapy to Combat Abnormal Bone Growth in FOP
A novel therapy combining stem cells and rapamycin effectively reduces abnormal bone formation in FOP, a rare genetic disorder, improving mobility and offering hope for future treatments.
Understanding the Development of Aortic Valve Stenosis
Research sheds light on the cellular mechanisms of aortic valve stenosis, highlighting differences between valve types and potential pathways for early intervention.